Nationwide Evaluation of Patient Selection for Minimally Invasive Distal Pancreatectomy Using American College of Surgeons' National Quality Improvement Program

Keyphrases

• Quality Improvement Program 100%
• Patient Selection 100%
• Patient Assessment 100%
• Minimally Invasive Distal Pancreatectomy 100%
• American College of Surgeons 100%
• Laparoscopic Distal Pancreatectomy 70%
• Major Morbidity 50%
• Selection Factors 50%
• Risk Factors 30%
• Body Mass Index 30%
• Benign Disease 20%
• Tumor Size 20%
• Pancreatic Ductal Adenocarcinoma 20%
• Actual Risk 20%
• Tumor 10%
• Surgical Technique 10%
• Odds Ratio 10%
• Retrospective Cohort Study 10%
• Neoadjuvant Therapy 10%
• Adverse Events 10%
• Potential Gains 10%
• Etiology 10%
• Low Risk 10%
• Exclusion Criteria 10%
• Reoperation 10%
• Physical Status 10%
• Outcome Prediction 10%
• Adverse Outcomes 10%
• Pancreas 10%
• Pancreatitis 10%
• Multivariable Modeling 10%
• Benign Tumor 10%
• Multivisceral 10%
• Laparoscopic-assisted 10%
• Underexploited 10%
• Widespread Adoption 10%
• Robot-assisted Approach 10%

INIS

• patients 100%
• risks 100%
• morbidity 100%
• evaluation 100%
• colleges 100%
• tumors 60%
• size 60%
• pancreas 60%
• diseases 40%
• comparative evaluations 40%
• adenocarcinomas 40%
• surgery 20%
• mortality 20%
• metrics 20%
• modeling 20%
• etiology 20%
• robots 20%

Medicine and Dentistry

• Surgeon 100%
• Patient Selection 100%
• Quality Improvement 100%
• Distal Pancreatectomy 100%
• Body Mass Index 17%
• Benign Tumor 17%
• Neoplasm 11%
• Pancreas Adenocarcinoma 11%
• Adverse Event 5%
• Surgical Technique 5%
• Retrospective Cohort Study 5%
• Adverse Outcome 5%
• Pancreatitis 5%
• Neoadjuvant Therapy 5%
• Reoperation 5%
• Odds Ratio 5%